United Pharm (033270) — Cash Flow-to-Debt Ratio
United Pharm (033270) has a Cash Flow-to-Debt Ratio of 0.34x as of March 2026, meaning its operating cash flow of ₩35.58 Billion could theoretically repay 0% of its total liabilities (₩103.96 Billion) in one year. Explore United Pharm strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
United Pharm Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for United Pharm across 14 annual periods. Also explore United Pharm asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for United Pharm (2011–2025)
Year-by-year debt coverage analysis for United Pharm. For market capitalisation and broader financial context, see market value of United Pharm.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | ₩51.14 Billion | ₩64.86 Billion | ▲ +99.3% |
| 2024 | 0.40x | ₩26.79 Billion | ₩67.72 Billion | ▼ -28.3% |
| 2023 | 0.55x | ₩49.77 Billion | ₩90.18 Billion | ▼ -30.7% |
| 2022 | 0.80x | ₩63.78 Billion | ₩80.03 Billion | ▲ +43.4% |
| 2021 | 0.56x | ₩44.09 Billion | ₩79.32 Billion | ▲ +15.1% |
| 2020 | 0.48x | ₩36.96 Billion | ₩76.54 Billion | ▼ -3.6% |
| 2019 | 0.50x | ₩38.15 Billion | ₩76.14 Billion | ▼ -0.1% |
| 2018 | 0.50x | ₩36.86 Billion | ₩73.47 Billion | ▲ +16.2% |
| 2017 | 0.43x | ₩27.68 Billion | ₩64.11 Billion | ▼ -18.3% |
| 2016 | 0.53x | ₩30.02 Billion | ₩56.83 Billion | ▲ +37.0% |
| 2014 | 0.39x | ₩21.31 Billion | ₩55.27 Billion | ▲ +5.9% |
| 2013 | 0.36x | ₩18.97 Billion | ₩52.10 Billion | ▼ -10.0% |
| 2012 | 0.40x | ₩21.88 Billion | ₩54.10 Billion | ▼ -16.5% |
| 2011 | 0.48x | ₩27.62 Billion | ₩57.04 Billion | — |